{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:39:05Z","timestamp":1774543145941,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The risk of congenital anomalies following in utero exposure to thionamide antithyroid drugs (ATDs) is unresolved. Observational studies are contradictory and existing meta\u2010analyses predate and preclude more recent studies. We undertook an updated meta\u2010analysis of congenital anomaly risk in women exposed to carbimazole or methimazole (CMZ\/MMI), propylthiouracil (PTU), or untreated hyperthyroidism in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched Medline, Embase, and the Cochrane database for articles published up till August 2021. We pooled separate crude and adjusted risk estimates using random effects models and subgroup analyses to address heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 16 cohort studies comprising 5957, 15,785, and 15,666 exposures to CMZ\/MMI, PTU, and untreated hyperthyroidism, respectively. Compared to nondisease controls, adjusted risk ratio (RR) and 95% confidence intervals (95% CIs) for congenital anomalies was increased for CMZ\/MMI (RR, 1.28; 95% CI, 1.06\u20131.54) and PTU (RR, 1.16; 95% CI, 1.08\u20131.25). Crude risk for CMZ\/MMI was increased relative to PTU (RR, 1.20; 95% CI, 1.01\u20131.43). Increased risk was also seen with exposure to both CMZ\/MMI and PTU, that is, women who switched ATDs in pregnancy (RR, 1.51; 95% CI, 1.14\u20131.99). However, the timing of ATD switch was highly variable and included prepregnancy switches in some studies. The excess number of anomalies per 1000 live births was 17.2 for patients exposed to CMZ\/MMI, 9.8, for PTU exposure, and 31.4 for exposure to both CMZ\/MMI and PTU. Risk in the untreated group did not differ from control or ATD groups. The untreated group was however highly heterogeneous in terms of thyroid status. Subgroup analysis showed more positive associations in studies with &gt;500 exposures and up to 1\u2010year follow\u2010up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ATD therapy carries a small risk of congenital anomalies which is higher for CMZ\/MMI than for PTU and does not appear to be reduced by switching ATDs in pregnancy. Due to key limitations in the available data, further studies will be required to clarify the risks associated with untreated hyperthyroidism and with switching ATDs in pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cen.14646","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:13:03Z","timestamp":1638270783000},"page":"857-868","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"96","author":[{"given":"Medha","family":"Agrawal","sequence":"first","affiliation":[{"name":"Thyroid Research Group, School of Medicine Cardiff University  Cardiff UK"},{"name":"Diabetes Department, Prince Charles Hospital Cwm Taf University Health Board  Pontypridd UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffan","family":"Lewis","sequence":"additional","affiliation":[{"name":"Diabetes Department, Prince Charles Hospital Cwm Taf University Health Board  Pontypridd UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-3700","authenticated-orcid":false,"given":"Lakdasa","family":"Premawardhana","sequence":"additional","affiliation":[{"name":"Thyroid Research Group, School of Medicine Cardiff University  Cardiff UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin M.","family":"Dayan","sequence":"additional","affiliation":[{"name":"Thyroid Research Group, School of Medicine Cardiff University  Cardiff UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3436-422X","authenticated-orcid":false,"given":"Peter N.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Thyroid Research Group, School of Medicine Cardiff University  Cardiff UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2221-992X","authenticated-orcid":false,"given":"Onyebuchi E.","family":"Okosieme","sequence":"additional","affiliation":[{"name":"Thyroid Research Group, School of Medicine Cardiff University  Cardiff UK"},{"name":"Diabetes Department, Prince Charles Hospital Cwm Taf University Health Board  Pontypridd UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3588"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000365101"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1054375"},{"issue":"6","key":"e_1_2_9_5_1","first-page":"946","article-title":"Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism","volume":"84","author":"Millar LK","year":"1994","journal-title":"Obstet Gynecol"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0678"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1748007"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000342920"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990305)83:1<43::AID-AJMG8>3.0.CO;2-C"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2017.1338944"},{"issue":"3","key":"e_1_2_9_11_1","first-page":"315","article-title":"Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum","volume":"27","author":"Alexander EK","year":"2017","journal-title":"Thyroid 2017"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000490384"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-01343"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1398"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1984.tb00119.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-020-00085-8"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126610"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(06)12"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180108"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14282"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa204"},{"issue":"1","key":"e_1_2_9_22_1","first-page":"71","article-title":"Antithyroid drug treatment and pregnancy outcomes among women with hyperthyroidism in pregnancy: a Norwegian population\u2010based registry\u2010linkage study","volume":"29","author":"El Khalil N","year":"2021","journal-title":"Norsk Epidemiologi"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14805"},{"key":"e_1_2_9_24_1","unstructured":"WellsGSB O'ConnellD PetersonJ WelchV LososM TugwellP. The Newcastle\u2010Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta\u2010analyses.2013.http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2380"},{"key":"e_1_2_9_26_1","volume-title":"Cochrane handbook for systematic reviews of interventions version 62 (updated February 2021)","author":"Sch\u00fcnemann HJ","year":"2021"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0314"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2831"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.03019.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1072"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0488"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0434"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(94)70390-6"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2860"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03495.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2016.03.003"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0621"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13731"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-9485-8_20"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0150"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.14646","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cen.14646","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.14646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T10:04:24Z","timestamp":1692957864000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.14646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1111\/cen.14646"],"URL":"https:\/\/doi.org\/10.1111\/cen.14646","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741276955.793590623","asserted-by":"object"}]},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"assertion":[{"value":"2021-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}